As the COVID-19 vaccine programme progresses, it is important to monitor and evaluate the vaccines against a broad range of outcomes. This helps to maintain public and healthcare professionals' confidence in the vaccines. It also ensures that surveillance systems are in place for long-term monitoring of the programme and its impact.

We are leading a broad range of surveillance work to do this in Scotland. We are working collaboratively with the MHRA, NHSScotland, Scottish Government and academic partners.

The work aims to:

  • monitor uptake and coverage of the vaccine in targeted populations and identifying under-vaccinated groups
  • rapidly detect and evaluate possible adverse events associated with the COVID-19 vaccination
  • estimate the effectiveness of the vaccine at preventing disease (including the effectiveness of preventing different variants and on the duration of any protective effect)
  • identify risk factors for and outcomes of vaccine effect and failure
  • monitor the impact on the prevalence of antibodies against COVID-19 as an indicator of population-level immunity
  • monitor attitudes to vaccination and identify barriers to vaccine uptake
  • monitor inequalities across various outcome measures.

More detail about our approach to the surveillance of COVID-19 vaccinations is provided in COVID-19 Vaccine Surveillance Strategy.

View the COVID-19 Vaccine Surveillance Strategy

The outcomes of the various aspects of the surveillance programme will be reported as they become available.

Last updated: 13 June 2022
Was this page helpful?